"Designing Growth Strategies is in our DNA"

Heparin Market Size, Share & COVID-19 Impact Analysis, By Product Type (Unfractionated Heparin (UFH), and Low Molecular Weight Heparin (LMWH)), By Source (Bovine, and Porcine), By Application (Deep Vein Thrombosis & Pulmonary Embolism, Atrial Fibrillation, Heart Attacks, Stroke, and Others), By Route of Administration (Intravenous Infusion, and Subcutaneous Injection), By End User (Hospitals & ASCs, Clinics, Others), and Regional Forecast, 2021-2028

Region : Global | Format: PDF | Report ID: FBI104447

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Key Industry Developments - Mergers, Acquisitions, and Partnerships
    2. New Product Launches
    3. Prevalence of Key Cardiovascular Diseases, By Key Countries
    4. China Heparin Market Overview
    5. Blood Clots: Stats & Facts
    6. Overview of Technological Advancements in Heparin
    7. Impact of COVID-19 on the Global Heparin Market
    8. Regulatory Scenario by Key Countries
    9. Reimbursement Scenario by Key Countries
    10. Trends of Heparin Consumption in Muslim-oriented Markets
    11. Insights on Usage of Unfractionated Heparin (UFH) & Low Molecular Weight Heparin (LMWH)
    12. China Heparin Market Overview (Production/ Supply Impacted by Swine Fever, etc.)
    13. Purchasing Process – Heparin
    14. Pricing of Heparin
  5. Global Heparin Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast– By Product Type
      1. Unfractionated Heparin (UFH)
      2. Low Molecular Weight Heparin (LMWH)
    3. Market Analysis, Insights and Forecast – By Source
      1. Bovine
      2. Porcine
    4. Market Analysis, Insights and Forecast– By Application
      1. Deep Vein Thrombosis & Pulmonary Embolism
      2. Atrial Fibrillation
      3. Heart Attacks
      4. Stroke
      5. Others
    5. Market Analysis, Insights and Forecast– By Route of Administration
      1. Intravenous Infusion
      2. Subcutaneous Injection
    6. Market Analysis, Insights and Forecast– By End User
      1. Hospitals & ASCs
      2. Clinics
      3. Others
    7. Market Analysis, Insights and Forecast– By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Heparin Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast  – By Product Type
      1. Unfractionated Heparin (UFH)
      2. Low Molecular Weight Heparin (LMWH)
    3. Market Analysis, Insights and Forecast  – By Source
      1. Bovine
      2. Porcine
    4. Market Analysis, Insights and Forecast  – By Application
      1. Deep Vein Thrombosis & Pulmonary Embolism
      2. Atrial Fibrillation
      3. Heart Attacks
      4. Stroke
      5. Others
    5. Market Analysis, Insights and Forecast – By Route of Administration
      1. Intravenous Infusion
      2. Subcutaneous Injection
    6. Market Analysis, Insights and Forecast  – By End User
      1. Hospitals & ASCs
      2. Clinics
      3. Others
    7. Market Analysis, Insights and Forecast  – By Country
      1. U.S.
      2. Canada
    8. U.S. Heparin Market Analysis, Insights and Forecast, 2017-2028
      1. Key Findings / Summary
      2. Market Analysis, Insights and Forecast  – By Product Type
        1. Unfractionated Heparin (UFH)
        2. Low Molecular Weight Heparin (LMWH)
      3. Market Analysis, Insights and Forecast  – By Source
        1. Bovine
        2. Porcine
      4. Market Analysis, Insights and Forecast  – By Application
        1. Deep Vein Thrombosis & Pulmonary Embolism
        2. Atrial Fibrillation
        3. Heart Attacks
        4. Stroke
        5. Others
      5. Market Analysis, Insights and Forecast – By Route of Administration
        1. Intravenous Infusion
        2. Subcutaneous Injection
      6. Market Analysis, Insights and Forecast  – By End User
        1. Hospitals & ASCs
        2. Clinics
        3. Others
  7. Europe Heparin Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast  – By Product Type
      1. Unfractionated Heparin (UFH)
      2. Low Molecular Weight Heparin (LMWH)
    3. Market Analysis, Insights and Forecast  – By Source
      1. Bovine
      2. Porcine
    4. Market Analysis, Insights and Forecast  – By Application
      1. Deep Vein Thrombosis & Pulmonary Embolism
      2. Atrial Fibrillation
      3. Heart Attacks
      4. Stroke
      5. Others
    5. Market Analysis, Insights and Forecast – By Route of Administration
      1. Intravenous Infusion
      2. Subcutaneous Injection
    6. Market Analysis, Insights and Forecast  – By End User
      1. Hospitals & ASCs
      2. Clinics
      3. Others
    7. Market Analysis, Insights and Forecast  – By Country/ Sub-Region
      1. U.K.
      2. Germany
      3. France
      4. Italy
      5. Spain
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Heparin Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast  – By Product Type
      1. Unfractionated Heparin (UFH)
      2. Low Molecular Weight Heparin (LMWH)
    3. Market Analysis, Insights and Forecast  – By Source
      1. Bovine
      2. Porcine
    4. Market Analysis, Insights and Forecast  – By Application
      1. Deep Vein Thrombosis & Pulmonary Embolism
      2. Atrial Fibrillation
      3. Heart Attacks
      4. Stroke
      5. Others
    5. Market Analysis, Insights and Forecast– By Route of Administration
      1. Intravenous Infusion
      2. Subcutaneous Injection
    6. Market Analysis, Insights and Forecast  – By End User
      1. Hospitals & ASCs
      2. Clinics
      3. Others
    7. Market Analysis, Insights and Forecast  – By Country/ Sub-Region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Heparin Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast  – By Product Type
      1. Unfractionated Heparin (UFH)
      2. Low Molecular Weight Heparin (LMWH)
    3. Market Analysis, Insights and Forecast  – By Source
      1. Bovine
      2. Porcine
    4. Market Analysis, Insights and Forecast  – By Application
      1. Deep Vein Thrombosis & Pulmonary Embolism
      2. Atrial Fibrillation
      3. Heart Attacks
      4. Stroke
      5. Others
    5. Market Analysis, Insights and Forecast – By Route of Administration
      1. Intravenous Infusion
      2. Subcutaneous Injection
    6. Market Analysis, Insights and Forecast  – By End User
      1. Hospitals & ASCs
      2. Clinics
      3. Others
    7. Market Analysis, Insights and Forecast  – By Country/ Sub-Region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Heparin Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast  – By Product Type
      1. Unfractionated Heparin (UFH)
      2. Low Molecular Weight Heparin (LMWH)
    3. Market Analysis, Insights and Forecast  – By Source
      1. Bovine
      2. Porcine
    4. Market Analysis, Insights and Forecast  – By Application
      1. Deep Vein Thrombosis & Pulmonary Embolism
      2. Atrial Fibrillation
      3. Heart Attacks
      4. Stroke
      5. Others
    5. Market Analysis, Insights and Forecast – By Route of Administration
      1. Intravenous Infusion
      2. Subcutaneous Injection
    6. Market Analysis, Insights and Forecast  – By End User
      1. Hospitals & ASCs
      2. Clinics
      3. Others
    7. Market Analysis, Insights and Forecast  – By Country/ Sub-Region
      1. South Africa
      2. GCC Countries
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Global Market Share Analysis (2020)
    2. Comparative Analysis – Major Players
    3. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
      1. Opocrin S.p.A.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. Baxter
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. Pfizer Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. Bioiberica S.A.U.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      5. Fresenius SE & Co. KGaA
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      6. Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      7. B. Braun Melsungen AG
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      8. Dr. Reddy’s Laboratories Ltd.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      9. LEO Pharma A/S
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      10. Aspen Holdings
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
Read Less

Figure 01: Global Heparin Market Revenue Breakdown (USD billion, %) by Region, 2020 & 2028

Figure 02: Global Heparin Market Value Share (%), By Product Type, 2020 & 2028

Figure 03: Global Heparin Market Value Share (%), By Source, 2020 & 2028

Figure 04: Global Heparin Market Value Share (%), By Application, 2020 & 2028

Figure 05: Global Heparin Market Value Share (%), By Route of Administration, 2020 & 2028

Figure 06: Global Heparin Market Value Share (%), By End User, 2020 & 2028

Figure 07: Global Heparin Market Value (USD billion), By Region, 2020 & 2028

Figure 08: North America Heparin Market Value (USD billion), By Product Type, 2020 & 2028

Figure 09: North America Heparin Market Value Share (%), By Product Type, 2020

Figure 10: North America Heparin Market Value (USD billion), By Source, 2020 & 2028

Figure 11: North America Heparin Market Value Share (%), By Source, 2020

Figure 12: North America Heparin Market Value (USD billion), By Application, 2020 & 2028

Figure 13: North America Heparin Market Value Share (%), By Application, 2020

Figure 14: North America Heparin Market Value (USD billion), By Route of Administration, 2020 & 2028

Figure 15: North America Heparin Market Value Share (%), By Route of Administration, 2020

Figure 16: North America Heparin Market Value (USD billion), By End User, 2020 & 2028

Figure 17: North America Heparin Market Value Share (%), By End User, 2020

Figure 18: North America Heparin Market Value (USD billion), By Country, 2020 & 2028

Figure 19: North America Heparin Market Value Share (%), By Country, 2020

Figure 20: U.S. Heparin Market Value (USD billion), By Product Type, 2020 & 2028

Figure 21: U.S. Heparin Market Value Share (%), By Product Type, 2020

Figure 22: U.S. Heparin Market Value (USD billion), By Source, 2020 & 2028

Figure 23: U.S. Heparin Market Value Share (%), By Source, 2020

Figure 24: U.S. Heparin Market Value (USD billion), By Application, 2020 & 2028

Figure 25: U.S. Heparin Market Value Share (%), By Application, 2020

Figure 26: U.S. Heparin Market Value (USD billion), By Route of Administration, 2020 & 2028

Figure 27: U.S. Heparin Market Value Share (%), By Route of Administration, 2020

Figure 28: U.S. Heparin Market Value (USD billion), By End User, 2020 & 2028

Figure 29: U.S. Heparin Market Value Share (%), By End User, 2020

Figure 30: Europe Heparin Market Value (USD billion), By Product Type, 2020 & 2028

Figure 31: Europe Heparin Market Value Share (%), By Product Type, 2020

Figure 32: Europe Heparin Market Value (USD billion), By Source, 2020 & 2028

Figure 33: Europe Heparin Market Value Share (%), By Source, 2020

Figure 34: Europe Heparin Market Value (USD billion), By Application, 2020 & 2028

Figure 35: Europe Heparin Market Value Share (%), By Application, 2020

Figure 36: Europe Heparin Market Value (USD billion), By Route of Administration, 2020 & 2028

Figure 37: Europe Heparin Market Value Share (%), By Route of Administration, 2020

Figure 38: Europe Heparin Market Value (USD billion), By End User, 2020 & 2028

Figure 39: Europe Heparin Market Value Share (%), By End User, 2020

Figure 40: Europe Heparin Market Value (USD billion), By Country/Sub-Region, 2020 & 2028

Figure 41: Europe Heparin Market Value Share (%), By Country/Sub-Region, 2020

Figure 42: Asia Pacific Heparin Market Value (USD billion), By Product Type, 2020 & 2028

Figure 43: Asia Pacific Heparin Market Value Share (%), By Product Type, 2020

Figure 44: Asia Pacific Heparin Market Value (USD billion), By Source, 2020 & 2028

Figure 45: Asia Pacific Heparin Market Value Share (%), By Source, 2020

Figure 46: Asia Pacific Heparin Market Value (USD billion), By Application, 2020 & 2028

Figure 47: Asia Pacific Heparin Market Value Share (%), By Application, 2020

Figure 48: Asia Pacific Heparin Market Value (USD billion), By Route of Administration, 2020 & 2028

Figure 49: Asia Pacific Heparin Market Value Share (%), By Route of Administration, 2020

Figure 50: Asia Pacific Heparin Market Value (USD billion), By End User, 2020 & 2028

Figure 51: Asia Pacific Heparin Market Value Share (%), By End User, 2020

Figure 52: Asia Pacific Heparin Market Value (USD billion), By Country/Sub-Region, 2020 & 2028

Figure 53: Asia Pacific Heparin Market Value Share (%), By Country/Sub-Region, 2020

Figure 54: Latin America Heparin Market Value (USD billion), By Product Type, 2020 & 2028

Figure 55: Latin America Heparin Market Value Share (%), By Product Type, 2020

Figure 56: Latin America Heparin Market Value (USD billion), By Source, 2020 & 2028

Figure 57: Latin America Heparin Market Value (USD billion), By Application, 2020 & 2028

Figure 58: Latin America Heparin Market Value Share (%), By Application, 2020

Figure 59: Latin America Heparin Market Value (USD billion), By Route of Administration, 2020 & 2028

Figure 60: Latin America Heparin Market Value Share (%), By Route of Administration, 2020

Figure 61: Latin America Heparin Market Value (USD billion), By End User, 2020 & 2028

Figure 62: Latin America Heparin Market Value Share (%), By End User, 2020

Figure 63: Latin America Heparin Market Value (USD billion), By Country/Sub-Region, 2020 & 2028

Figure 64: Latin America Heparin Market Value Share (%), By Country/Sub-Region, 2020

Figure 65: Latin America Heparin Market Value Share (%), By Source, 2020

Figure 66: Middle East & Africa Heparin Market Value (USD billion), By Product Type, 2020 & 2028

Figure 67: Middle East & Africa Heparin Market Value Share (%), By Product Type, 2020

Figure 68: Middle East & Africa Heparin Market Value (USD billion), By Source, 2020 & 2028

Figure 69: Middle East & Africa Heparin Market Value Share (%), By Source, 2020

Figure 70: Middle East & Africa Heparin Market Value (USD billion), By Application, 2020 & 2028

Figure 71: Middle East & Africa Heparin Market Value Share (%), By Application, 2020

Figure 72: Middle East & Africa Heparin Market Value (USD billion), By Route of Administration, 2020 & 2028

Figure 73: Middle East & Africa Heparin Market Value Share (%), By Route of Administration, 2020

Figure 74: Middle East & Africa Heparin Market Value (USD billion), By End User, 2020 & 2028

Figure 75: Middle East & Africa Heparin Market Value Share (%), By End User, 2020

Figure 76: Middle East & Africa Heparin Market Value (USD billion), By Country/Sub-Region, 2020 & 2028

Figure 77: Middle East & Africa Heparin Market Value Share (%), By Country/Sub-Region, 2020

Figure 78: Global Heparin Market Share Analysis, By Company, 2020

Table 01: Global Heparin Market Revenue (USD billion) Forecast, By Product Type, 2017 - 2028

Table 02: Global Heparin Market Revenue (USD billion) Forecast, By Source, 2017 - 2028

Table 03: Global Heparin Market Revenue (USD billion) Forecast, By Application, 2017 - 2028

Table 04: Global Heparin Market Revenue (USD billion) Forecast, By Route of Administration, 2017 - 2028

Table 05: Global Heparin Market Revenue (USD billion) Forecast, By End User, 2017 - 2028

Table 06: Global Heparin Market Revenue (USD billion) Forecast, by Region, 2017-2028

Table 07: North America Heparin Market Revenue (USD billion) Forecast, By Product Type, 2017-2028

Table 08: North America Heparin Market Revenue (USD billion) Forecast, By Source, 2017-2028

Table 09: North America Heparin Market Revenue (USD billion) Forecast, By Application, 2017 - 2028

Table 10: North America Heparin Market Revenue (USD billion) Forecast, By Route of Administration, 2017 - 2028

Table 11: North America Heparin Market Revenue (USD billion) Forecast, By End User, 2017 - 2028

Table 12: North America Heparin Market Revenue (USD billion) Forecast, By Country, 2017-2028

Table 13: U.S. Heparin Market Revenue (USD billion) Forecast, By Product Type, 2017-2028

Table 14: U.S. Heparin Market Revenue (USD billion) Forecast, By Source, 2017-2028

Table 15: U.S. Heparin Market Revenue (USD billion) Forecast, By Application, 2017-2028

Table 16: U.S. Heparin Market Revenue (USD billion) Forecast, By Route of Administration, 2017-2028

Table 17: U.S. Heparin Market Revenue (USD billion) Forecast, By End User, 2017-2028

Table 18: Europe Heparin Market Revenue (USD billion) Forecast, By Product Type, 2017-2028

Table 19: Europe Heparin Market Revenue (USD billion) Forecast, By Source, 2017-2028

Table 20: Europe Heparin Market Revenue (USD billion) Forecast, By Application, 2017 - 2028

Table 21: Europe Heparin Market Revenue (USD billion) Forecast, By Route of Administration, 2017 - 2028

Table 22: Europe Heparin Market Revenue (USD billion) Forecast, By End User, 2017 - 2028

Table 23: Europe Heparin Market Revenue (USD billion) Forecast, By Country/Sub-Region, 2017 - 2028

Table 24: Asia Pacific Heparin Market Revenue (USD billion) Forecast, By Product Type, 2017-2028

Table 25: Asia Pacific Heparin Market Revenue (USD billion) Forecast, By Source, 2017-2028

Table 26: Asia Pacific Heparin Market Revenue (USD billion) Forecast, By Application, 2017 - 2028

Table 27: Asia Pacific Heparin Market Revenue (USD billion) Forecast, By Route of Administration, 2017 - 2028

Table 28: Asia Pacific Heparin Market Revenue (USD billion) Forecast, By End User, 2017 - 2028

Table 29: Asia Pacific Heparin Market Revenue (USD billion) Forecast, By Country/Sub-Region, 2017 - 2028

Table 30: Latin America Heparin Market Revenue (USD billion) Forecast, By Product Type, 2017-2028

Table 31: Latin America Heparin Market Revenue (USD billion) Forecast, By Source, 2017-2028

Table 32: Latin America Heparin Market Revenue (USD billion) Forecast, By Application, 2017 - 2028

Table 33: Latin America Heparin Market Revenue (USD billion) Forecast, By Route of Administration, 2017 - 2028

Table 34: Latin America Heparin Market Revenue (USD billion) Forecast, By End User, 2017 - 2028

Table 35: Latin America Heparin Market Revenue (USD billion) Forecast, By Country/Sub-Region, 2017 - 2028

Table 36: Middle East & Africa Heparin Market Revenue (USD billion) Forecast, By Product Type, 2017-2028

Table 37: Middle East & Africa Heparin Market Revenue (USD billion) Forecast, By Source, 2017-2028

Table 38: Middle East & Africa Heparin Market Revenue (USD billion) Forecast, By Application, 2017 - 2028

Table 39: Middle East & Africa Heparin Market Revenue (USD billion) Forecast, By Route of Administration, 2017 - 2028

Table 40: Middle East & Africa Heparin Market Revenue (USD billion) Forecast, By End User, 2017 - 2028

Table 41: Middle East & Africa Heparin Market Revenue (USD billion) Forecast, By Country/Sub-Region, 2017 - 2028

  • Jan, 2022
  • 2020
  • 2017-2019
  • 138

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $7850
    Book Now

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X